Sherwin-Williams (NYSE:SHW – Get Free Report) had its target price hoisted by stock analysts at BMO Capital Markets from $400.00 to $425.00 in a note issued to investors on Monday, Benzinga reports. The firm currently has an “outperform” rating on the specialty chemicals company’s stock. BMO Capital Markets’ target price suggests a potential upside of 12.21% from the stock’s current price.
Other research analysts have also issued research reports about the company. Morgan Stanley boosted their price target on Sherwin-Williams from $338.00 to $375.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 24th. Wells Fargo & Company boosted their target price on shares of Sherwin-Williams from $320.00 to $350.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 24th. Jefferies Financial Group upped their target price on shares of Sherwin-Williams from $392.00 to $415.00 and gave the company a “buy” rating in a report on Monday, August 26th. Redburn Atlantic upgraded shares of Sherwin-Williams to a “strong-buy” rating in a research note on Thursday, July 18th. Finally, Evercore ISI increased their price target on Sherwin-Williams from $365.00 to $380.00 and gave the company an “outperform” rating in a research note on Friday, August 30th. One research analyst has rated the stock with a sell rating, six have given a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Sherwin-Williams currently has an average rating of “Moderate Buy” and an average price target of $370.39.
View Our Latest Report on Sherwin-Williams
Sherwin-Williams Price Performance
Sherwin-Williams (NYSE:SHW – Get Free Report) last announced its quarterly earnings results on Tuesday, July 23rd. The specialty chemicals company reported $3.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.51 by $0.19. Sherwin-Williams had a net margin of 10.92% and a return on equity of 75.58%. The company had revenue of $6.27 billion during the quarter, compared to analyst estimates of $6.33 billion. During the same quarter in the previous year, the business earned $3.29 EPS. The firm’s revenue was up .5% on a year-over-year basis. As a group, research analysts forecast that Sherwin-Williams will post 11.47 EPS for the current year.
Insider Buying and Selling
In other Sherwin-Williams news, CFO Allen J. Mistysyn sold 14,520 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $366.83, for a total transaction of $5,326,371.60. Following the completion of the transaction, the chief financial officer now owns 63,520 shares in the company, valued at approximately $23,301,041.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.60% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Sherwin-Williams
Institutional investors have recently added to or reduced their stakes in the business. Waterloo Capital L.P. acquired a new position in Sherwin-Williams during the 4th quarter worth approximately $360,000. Valeo Financial Advisors LLC increased its stake in Sherwin-Williams by 7.9% during the 2nd quarter. Valeo Financial Advisors LLC now owns 2,636 shares of the specialty chemicals company’s stock valued at $787,000 after purchasing an additional 193 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its holdings in Sherwin-Williams by 7.2% during the first quarter. Massmutual Trust Co. FSB ADV now owns 1,533 shares of the specialty chemicals company’s stock worth $532,000 after buying an additional 103 shares during the last quarter. Brevan Howard Capital Management LP lifted its stake in shares of Sherwin-Williams by 259.1% in the fourth quarter. Brevan Howard Capital Management LP now owns 6,998 shares of the specialty chemicals company’s stock valued at $2,183,000 after buying an additional 5,049 shares in the last quarter. Finally, Transcend Capital Advisors LLC raised its holdings in shares of Sherwin-Williams by 24.1% in the 2nd quarter. Transcend Capital Advisors LLC now owns 7,805 shares of the specialty chemicals company’s stock worth $2,329,000 after acquiring an additional 1,514 shares during the last quarter. 77.67% of the stock is owned by institutional investors and hedge funds.
About Sherwin-Williams
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
See Also
- Five stocks we like better than Sherwin-Williams
- What Makes a Stock a Good Dividend Stock?
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- NYSE Stocks Give Investors a Variety of Quality Options
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.